Sign Up to like & get
recommendations!
1
Published in 2022 at "Canadian Respiratory Journal"
DOI: 10.1155/2022/3726395
Abstract: Sarcoidosis is a systemic granulomatous disease of unknown etiology. The diagnosis of sarcoidosis is based on clinicopathologic findings accompanied by the formation of granulomas in multiple organs, including the lung. Although angiotensin-converting enzyme (ACE) and…
read more here.
Keywords:
sarcoidosis;
nse levels;
diagnosis;
neuron specific ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2019 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2019.37.7_suppl.278
Abstract: 278 Background: NEPC, de novo or treatment-related in late stage CRPC, is a distinct entity with poor prognosis. Developing non-invasive methods for detection of NEPC is important for clinical practice and trial enrollment. We previously…
read more here.
Keywords:
serum;
cga;
nse cga;
study ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2022 at "Cancer Management and Research"
DOI: 10.2147/cmar.s349082
Abstract: Background Transformation to a lung neuroendocrine tumor (LNET) is a mechanism of resistance to epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKI). Serum neuron-specific enolase (NSE) is a useful marker in the detection of…
read more here.
Keywords:
egfr tki;
neuroendocrine tumor;
tumor;
transformation ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2023 at "Neuropsychiatric Disease and Treatment"
DOI: 10.2147/ndt.s400925
Abstract: Purpose Neuron-specific enolase (NSE) is considered a biomarker for the severity of nervous system diseases. We sought to explore whether serum NSE concentration in ischemic stroke patients undergoing mechanical thrombectomy (MT) is related to 3-month…
read more here.
Keywords:
clinical outcomes;
poor outcome;
month;
neuron specific ... See more keywords
Sign Up to like & get
recommendations!
2
Published in 2022 at "Frontiers in Cellular Neuroscience"
DOI: 10.3389/fncel.2022.788150
Abstract: Background Mild cognitive impairment (MCI) is considered a pre-stage of different dementia syndromes. Despite diagnostic criteria refined by DSM-5 and a new term for MCI – “mild neurocognitive disorder” (mild NCD) – this diagnosis is…
read more here.
Keywords:
mild;
mild cognitive;
mild ncd;
cognitive impairment ... See more keywords